Giovanni Morrone

Prof. Giovanni Morrone

Laboratory of Molecular Haematopoiesis and Stem Cell Biology, Universita degli studi Magna Graecia di Catanzaro, Catanzaro, Italy
orcid

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 1997 in Gastroenterology
Verified
Journal Article
Closed access
GMG Monteleone
G Monteleone
LBL Biancone
L Biancone
RMR Marasco
R Marasco
GMGiovanni Morrone
Giovanni Morrone
OMO Marasco
O Marasco
FPF Pallone
F Pallone

1 September 1988 in Journal of Biological Chemistry
Verified
Journal Article
Open access
GMGiovanni Morrone
Giovanni Morrone
Gennaro CilibertoGennaro Ciliberto
Gennaro Ciliberto
SOS Oliviero
S Oliviero
RAR Arcone
R Arcone
LDL Dente
L Dente
RCR Cortese
R Cortese
The phenomenon of acute phase (AP) response can be reproduced in vitro using cultured cells of hepatic origin by stimulation with the crude supernatant of activated monocytes (MoCM). Several monocyte-derived factors have been identified which might be responsible, alone or in combination, for the induction of AP response, but recently the attention has been focused on interleukin 6 (IL-6). We have previously shown that part of the AP response consists of the increase in the rate of transcription of the AP genes. Here we have treated the human hepatoma cell line Hep 3B with either crude MoCM or recombinant IL-6 and compared the effect of the two stimulants on the expression of both endogenous AP genes and recombinant plasmids introduced into the cells by transfection. The transfected plasmids contained the 5'-flanking region of AP genes fused to the coding region of the bacterial chloramphenicol acetyltransferase gene. We observe that the induction of mRNA accumulation of the endogenous genes corresponds to the transcriptional activation of the chloramphenicol acetyltransferase fusions. This is good evidence that the effect of IL-6 is totally or partially exerted at the level of transcription and that short segments of the 5'-flanking sequences of the inducible genes contain IL-6-responsive elements. Our results show that IL-6 is fully effective only on some of all the genes induced or repressed by MoCM, whereas others are only partially affected or totally nonresponsive.

6 September 2004 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JSJan Jacob Schuringa
Jan Jacob Schuringa
KCKi Young Chung
Ki Young Chung
GMGiovanni Morrone
Giovanni Morrone
MMMalcolm A.S. Moore
Malcolm A.S. Moore
Activation of the transcription factor signal transducer and activator of transcription (STAT)5 is involved in various aspects of hematopoiesis, affecting cell proliferation, differentiation, and cell survival. Constitutive activation of STAT5 has also been associated with leukemic transformation. We overexpressed the constitutively active mutant STAT5A(1*6) in human cord blood CD34+ cells and evaluated the effects on the hematopoietic potential of stem cells in a variety of in vitro and in vivo systems. The observed phenotypic changes were correlated with differential gene expression patterns induced by STAT5A(1*6). Our data indicate that a persistent activation of STAT5A in human hematopoietic stem and progenitor cells results in their enhanced self-renewal and diverts differentiation to the erythroid lineage.

26 November 2012 in Leukemia
Verified
Journal Article
Closed access
SHS J Horton
S J Horton
JJJ Jaques
J Jaques
CWC Woolthuis
C Woolthuis
JDJ van Dijk
J van Dijk
MMMaria Mesuraca
Maria Mesuraca
JSJ J Schuringa
J J Schuringa

28 April 2000 in Leukemia
Verified
Journal Article
Open access
PDF file
PTPierfrancesco Tassone
Pierfrancesco Tassone
SFS Forciniti
S Forciniti
EGE Galea
E Galea
GMGiovanni Morrone
Giovanni Morrone
MTMaria Caterina Turco
Maria Caterina Turco
SVS Venuta
S Venuta
Bisphosphonates (BPs) are commonly used in the treatment of myeloma-associated osteolytic lesions. Recent reports have suggested that BPs may also exert direct antitumor effects on myeloma cells. Here, we show that the treatment of myeloma cell lines with the combination of the potent BP zoledronate and dexamethasone inhibits cell growth and synergistically induces apoptotic cell death, providing a rationale for potential applications in vivo.

1 October 1985 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
MTMaria Caterina Turco
Maria Caterina Turco
MFM De Felice
M De Felice
LCL Corbo
L Corbo
GMGiovanni Morrone
Giovanni Morrone
RMR Mertelsmann
R Mertelsmann
SVS Venuta
S Venuta
The role of HLA Class I antigens in T cell proliferation was investigated by using the anti-HLA Class I monoclonal antibodies (MoAb) CR10-215, CR10-325, and CR11-115. MoAb CR10-215 and CR11-115 recognize the same (or spatially close) monomorphic determinant, which is distinct and spatially distant from that reacting with MoAb CR10-325. Addition of MoAb CR10-215 and CR11-115 to cultures of peripheral blood mononuclear cells stimulated with MoAb OKT3, MoAb Pan T2, PHA, or PPD inhibited cell proliferation. The blocking is specific in that the anti-HLA Class I MoAb CR10-325 and the Pan T MoAb Pan T1 had no effect on the proliferation. The inhibitory activity of MoAb CR10-215 and CR11-115 does not reflect i) toxic effects, ii) induction of suppressor cells and factors, iii) blocking of the binding of mitogens to lymphocytes, iv) inhibition of the production of interleukin 1 (IL 1) and interleukin 2 (IL 2), or v) function of IL 2 receptor. Anti-HLA Class I MoAb were able to inhibit the proliferation of purified, Tac-, T cells. The inhibited cells did not express Tac antigen, as assayed by direct immunofluorescence, with MoAb anti-Tac, but released a normal amount of IL 2 in culture medium. These results indicate that monomorphic determinants of the HLA Class I complex are involved in the regulation of T cell proliferation. The effect appears to occur at the level of IL 2 receptor expression.